FJ
Jornayvaz, François
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Interleukin-18 binding protein deficiency results in gut microbiota dysbiosis and aggravated diet-induced MASH in mice | JHEP reports |  | 2026 | 23 | 11 | ||
| Autoimmunity in MASLD : Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors | European journal of clinical investigation | | 2025 | 73 | 179 | ||
| Prise en charge de la dyslipidémie diabétique | Revue médicale suisse |  | 2025 | 5 | 0 | ||
| Autoantibodies against apolipoprotein A-1 and cadmium : possible links tocardiovascular and liver diseases across multiple models | ESC (European Society of Cardiology) Congress 2025 | 2025 | 7 | 0 | |||
| Autoantibodies against apolipoprotein A-1 and cadmium : Possible links tocardiovascular and liver diseases across multiple models | 93rd EAS (European Atherosclerosis Society) Congress | 2025 | 9 | 0 | |||
| Analogues du GLP-1 dans le traitement du diabète de type 2 et de l’obésité : la panacée ? | Revue médicale suisse | | 2025 | 6 | 0 | ||
| Multi-omics correlates of insulin resistance and circadian parameters mapped directly from human serum | EJN. European journal of neuroscience | | 2024 | 81 | 147 | ||
| Alterations of lipid homeostasis in morbid obese patients are partly reversed by bariatric surgery | iScience | | 2024 | 87 | 62 | ||
| S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects | Science advances | | 2024 | 338 | 151 | ||
| Linking antibody against apolipoprotein A-1 to nonalcoholic steatohepatitis in mice | 92nd EAS (European Atherosclerosis Society) Congress | 2024 | 5 | 0 | |||
| Corticosteroid therapy in older adults with cancer : Expert recommendations from a task force of the International Society of Geriatric Oncology | Journal of geriatric oncology | | 2024 | 36 | 0 | ||
| Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associatedsteatohepatitis in mice | ESC (Europan Society of Cardiology) Congress 2024 | 2024 | 3 | 0 | |||
| Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals,cardiovascular and liver diseases in the general population | ESC (Europan Society of Cardiology) Congress 2024 | 2024 | 8 | 0 | |||
| Diabétologie : ce qui a changé en 2023 | Revue médicale suisse | | 2024 | 107 | 5 | ||
| Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release | Diabetes | | 2024 | 366 | 3 | ||
| N ADPH oxidases in healthy white adipose tissue and in obesity : function, regulation, and clinical implications | Obesity | | 2024 | 105 | 76 | ||
| Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice | International journal of molecular sciences | | 2024 | 120 | 112 | ||
| Gastroparésie diabétique et diabète de type 1 | Revue médicale suisse | | 2024 | 122 | 2 | ||
| Langerhans Cell Histiocytosis of the Suprasellar Region : Diagnosis on Thyroid Cytology | European thyroid journal | | 2024 | 119 | 152 | ||
| Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals, cardiovascular and liver diseases in the general population | 92nd EAS (European Atherosclerosis Society) Congress | 2024 | 7 | 0 | |||
| Gynécologie-obstétrique. Prise en charge et dépistage du diabète gestationnel : ce qui a changé en 2023 | Revue médicale suisse | | 2024 | 211 | 2 | ||
| Toutes nos différences… | Revue médicale suisse | | 2024 | 68 | 2 | ||
| Interprofessional diabetes and foot management in low-and middle-income countries or humanitarian crises contexts | International Diabetes Federation (IDF) virtual congress | | 2023 | 56 | 82 | ||
| Pied diabétique : une prise en charge complexe et multidisciplinaire | Revue médicale suisse | | 2023 | 129 | 31 | ||
| Nonalcoholic fatty liver disease in type 1 diabetes : where are we? | Polskie Archiwum Medycyny Wewnętrznej | | 2023 | 89 | 64 | ||
| GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes | Diabetes & metabolism | | 2023 | 133 | 381 | ||
| A global research priority agenda to advance public health responses to fatty liver disease | Journal of hepatology | | 2023 | 120 | 288 | ||
| Diabétologie : ce qui a changé en 2022 | Revue médicale suisse | | 2023 | 142 | 15 | ||
| Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease | International journal of molecular sciences | | 2023 | 128 | 107 | ||
| Circadian organization of lipid landscape is perturbed in type 2 diabetic patients | Cell reports. Medicine | | 2023 | 270 | 139 | ||
| Stéatopathie non alcoolique (NAFLD) et diabète : le mauvais mariage | Revue médicale suisse | | 2023 | 128 | 34 | ||
| Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing | European thyroid journal | | 2023 | 211 | 267 | ||
| Traitement du diabète de type 2 : et si nous revenions à l’essentiel ? | Revue médicale suisse | | 2023 | 93 | 16 | ||
| A multi–society Delphi consensus statement on new fatty liver disease nomenclature | Journal of hepatology | | 2023 | 130 | 844 | ||
| The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas | Endocrine | | 2023 | 143 | 219 | ||
| Neuropathie diabétique : mise au point | Revue Médicale Suisse | | 2022 | 163 | 691 | ||
| Effectiveness of Therapeutic Patient Education Interventions in Obesity and Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Nutrients | | 2022 | 187 | 234 | ||
| NAFLD: From Mechanisms to Therapeutic Approaches | Biomedicines | | 2022 | 152 | 175 | ||
| Allergie à l’insuline : comment faire ? | Revue médicale suisse | | 2022 | 140 | 237 | ||
| Non-alcoholic fatty liver disease in type 1 diabetes: prevalence and pathophysiology | Frontiers in endocrinology | | 2022 | 155 | 277 | ||
| Diabète pancréatoprive | Revue médicale suisse | | 2022 | 537 | 153 | ||
| Pheochromocytoma presented by Takotsubo, unmasked by accumulation of paroxetine, in a cytochrome poor metabolizer patient: A case report | Thérapie | | 2022 | 366 | 1 | ||
| Interleukin-18 in metabolism: from mice physiology to human diseases | Frontiers in endocrinology | | 2022 | 181 | 304 | ||
| Canakinumab in patients with COVID-19 and type 2 diabetes – a multicentre, randomised, double-blind, placebo-controlled trial | EClinicalMedicine | | 2022 | 132 | 111 | ||
| Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity | Endocrine connections | | 2022 | 234 | 156 | ||
| (650) Efficacy of therapeutic patient education interventions in metabolic disorders: a systematic review and meta-analysis | 58th EASD Annual Meeting of the European Association for the Study of Diabetes | 2022 | 246 | 7 | |||
| Circulating 1,5-anhydroglucitol as a biomarker of ß-cell mass independent of a diabetes phenotype in human subjects | Journal of clinical endocrinology & metabolism | | 2022 | 417 | 2 | ||
| Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days | Annals of surgery | | 2022 | 258 | 355 | ||
| NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook | Antioxidants | | 2022 | 277 | 421 | ||
| Dernières recommandations européennes sur les dyslipidémies | Revue médicale suisse | | 2022 | 388 | 782 | ||
| Hepatic non-parenchymal S100A9-TLR4-mTORC1 axis normalizes diabetic ketogenesis | Nature communications | | 2022 | 378 | 113 | ||
| Diabète : la pandémie comme révélateur de nos succès/nos failles | Revue médicale suisse | | 2022 | 53 | 28 | ||
| Diabétologie | Revue médicale suisse | | 2022 | 92 | 63 | ||
| Hépatopathie et diabète de type 2 | Leading Opinions. Médecine Interne | | 2022 | 119 | 0 | ||
| Tratamiento podológico del pie diabético | Encyclopédie médico-chirurgicale. Podología | | 2022 | 118 | 0 | ||
| Systematic Review and Meta-Analysis of the Usefulness of Epicardial Fat Thickness as a Non-Invasive Marker of the Presence and Severity of Nonalcoholic Fatty Liver Disease | Biomedicines | | 2022 | 155 | 120 | ||
| Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes | Cardiovascular diabetology | | 2022 | 112 | 295 | ||
| Prise en charge podologique du pied diabétique | Encyclopédie médico-chirurgicale. Podologie | | 2022 | 141 | 0 | ||
| Growth differentiation factor-15 prevents glucotoxicity and connexin-36 downregulation in pancreatic beta-cells | Molecular and cellular endocrinology | | 2022 | 105 | 148 | ||
| Le diabète : une pandémie oubliée ? | Revue médicale suisse | | 2021 | 125 | 250 | ||
| Inhibiteurs du SGLT2 : que des bénéfices? | Revue médicale suisse | | 2021 | 380 | 287 | ||
| Is routine measurement of the serum C-reactive protein level helpful during antibiotic therapy for diabetic foot infection? | Diabetes, Obesity and Metabolism | | 2021 | 189 | 0 | ||
| Diabète de type MODY : une entité souvent méconnue | Revue médicale suisse | | 2021 | 179 | 171 | ||
| Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients | Acta Physiologica | | 2021 | 398 | 3 | ||
| Diabétologie | Revue médicale suisse | | 2021 | 204 | 2 | ||
| Pathophysiology of NASH in endocrine diseases | Endocrine Connections | | 2021 | 223 | 200 | ||
| Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD | International journal of molecular sciences | | 2021 | 154 | 227 | ||
| Diabétologie | Revue médicale suisse | | 2020 | 243 | 2 | ||
| Diabète: et si on se mettait à la place du patient? | Revue médicale suisse | | 2020 | 246 | 0 | ||
| Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting | Diabetes, Obesity and Metabolism | | 2020 | 487 | 334 | ||
| Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a swiss population | BMJ Open Diabetes Res Care | | 2020 | 338 | 175 | ||
| Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland | Diabetes, Metabolic Syndrome and Obesity | | 2020 | 301 | 195 | ||
| La NASH: une complication moins connue mais importante du diabète | Revue médicale suisse | | 2020 | 357 | 0 | ||
| The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet | Translational Research | | 2020 | 563 | 305 | ||
| Quelle place pour les inhibiteurs de la DPP-4 en 2020? | Revue médicale suisse | | 2020 | 550 | 0 | ||
| Ulcère du pied chez un patient avec un diabète : quelle prise en charge médico-chirurgicale ? | Revue médicale suisse | | 2020 | 332 | 1 | ||
| Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report | BMC Endocrine Disorders | | 2020 | 207 | 134 | ||
| Diabète après transplantation rénale : mise au point | Revue médicale suisse | | 2020 | 354 | 4 | ||
| Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial | Clinical Infectious Diseases | | 2020 | 345 | 873 | ||
| Insuffisance rénale chronique et nouveaux traitements antidiabétiques : tour d'horizon en 2019 | Revue médicale suisse | | 2019 | 675 | 280 | ||
| Thirteen-year trends in the prevalence of diabetes in an urban region of Switzerland: a population-based study | Diabetic Medicine | | 2019 | 263 | 0 | ||
| Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus | Endocrine Connections | | 2019 | 321 | 116 | ||
| Faut-il prescrire plus d'inhibiteurs SGLT-2 ? | Revue médicale suisse | | 2019 | 305 | 142 | ||
| [News in diabetology 2018] | Revue médicale suisse | | 2019 | 274 | 92 | ||
| Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism | Scientific Reports | | 2019 | 471 | 131 | ||
| Nonalcoholic fatty liver disease burden | Swiss Medical Weekly | | 2019 | 313 | 210 | ||
| Prise en charge de la dyslipidémie chez les patients avec un diabète de type 1 | Revue médicale suisse | | 2018 | 519 | 54 | ||
| Diabétologie | Revue médicale suisse | | 2018 | 417 | 60 | ||
| Observance thérapeutique et empilage médicamenteux | Revue médicale suisse | | 2018 | 368 | 182 | ||
| Fibroblast Growth Factor 15/19 - From Basic Functions to Therapeutic Perspectives | Endocrine Reviews | | 2018 | 499 | 216 | ||
| Transition optimale hôpital-domicile d'un patient diabétique de type 2 : quelques outils | Revue médicale suisse | | 2018 | 566 | 155 | ||
| Consequences of the Adoption of the IADPSG versus Carpenter and Coustan Criteria to Diagnose Gestational Diabetes: A Before-After Comparison | Experimental and Clinical Endocrinology and Diabetes | | 2018 | 515 | 2 | ||
| An Overview on Diabetic Foot Infections, including Issues Related to Associated Pain, Hyperglycemia and Limb Ischemia | Current Pharmaceutical Design | | 2018 | 490 | 1 | ||
| Diabète prégestationnel : une entité de plus en plus fréquente | Revue médicale suisse | | 2018 | 508 | 188 | ||
| Diabète de type 1, activité physique et nouvelles technologies | Revue médicale suisse | | 2018 | 769 | 380 | ||
| β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue | JCI insight | | 2017 | 585 | 290 | ||
| Utilité de la mesure en continu de la glycémie chez les patients diabétiques de type 2 | Revue médicale suisse | | 2017 | 392 | 0 | ||
| Treatment challenges in type 1 diabetes after roux-en-Y gastric bypass | Swiss Medical Weekly | | 2017 | 411 | 206 | ||
| AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice | Molecular Metabolism | | 2017 | 417 | 0 | ||
| Diabète sucré secondaire à une endocrinopathie : quand y penser ? | Revue médicale suisse | | 2017 | 549 | 1,022 | ||
| Diètes cétogènes : la solution miracle ? | Revue médicale suisse | | 2017 | 1,340 | 670 | ||
| Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies | Nutrients | | 2017 | 468 | 0 | ||
| Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease | Nutrients | | 2017 | 490 | 0 | ||
| Traitement du diabète: quand faire appel au diabétologue? | Revue médicale suisse | | 2017 | 372 | 208 | ||
| Grip strength is not associated with incident type 2 diabetes mellitus in healthy adults: The CoLaus study | Diabetes Research and Clinical Practice | | 2017 | 472 | 0 | ||
| Diabétologie | Revue médicale suisse | | 2017 | 408 | 116 | ||
| GPR40 mediates potential positive effects of a saturated fatty acid enriched diet on bone | Molecular Nutrition and Food Research | | 2017 | 565 | 422 | ||
| Effects of Antidiabetic Drugs on Gut Microbiota Composition | Genes | | 2017 | 441 | 0 | ||
| Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid | Dermatology | | 2017 | 426 | 0 | ||
| Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples | Journal of Immunological Methods | | 2017 | 398 | 1 | ||
| Place des nouveaux antidiabétiques dans la population gériatrique | Revue médicale suisse | | 2016 | 419 | 1 | ||
| Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance | FASEB Journal | | 2016 | 370 | 0 | ||
| Fasting glycaemia to simplify screening for gestational diabetes | BJOG: an International Journal of Obstetrics and Gynaecology | | 2016 | 592 | 1 | ||
| Diabète gestationnel – quelles sont les approches non médicales ? | Revue médicale suisse | | 2016 | 427 | 1 | ||
| Comment faire pour prévenir le diabète de type 2 en Suisse? | Revue médicale suisse | | 2016 | 421 | 2 | ||
| Leptin as a Potential Regulator of FGF21 | Cellular physiology and biochemistry | | 2016 | 628 | 246 | ||
| Preserving of Postnatal Leptin Signaling in Obesity-Resistant Lou/C Rats following a Perinatal High-Fat Diet | PloS one | | 2016 | 519 | 207 | ||
| Sécurité cardiovasculaire des antidiabétiques | Revue médicale suisse | | 2016 | 428 | 0 | ||
| Diabétologie | Revue médicale suisse | | 2016 | 374 | 0 | ||
| Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection | Arteriosclerosis, Thrombosis, and Vascular Biology | | 2016 | 618 | 1 | ||
| Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study | Cardiovascular Diabetology | | 2016 | 536 | 233 | ||
| Endocrine causes of nonalcoholic fatty liver disease | World Journal of Gastroenterology | | 2015 | 485 | 0 | ||
| Free Fatty Acids Impair FGF21 Action in HepG2 Cells | Cellular physiology and biochemistry | | 2015 | 560 | 385 | ||
| Metformine : nouvelles données pour une ancienne molécule | Revue médicale suisse | | 2015 | 449 | 2 | ||
| Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21 | Journal of Endocrinology | | 2015 | 823 | 391 | ||
| Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | Molecular and Cellular Endocrinology | | 2015 | 540 | 1,653 | ||
| Classification du diabète : vers une hétérogénéité croissante | Revue médicale suisse | | 2015 | 395 | 0 | ||
| Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue | PloS one | | 2015 | 623 | 332 | ||
| Le diabète en 2015 : en augmentation constante, mais avec une offre thérapeutique qui s'élargit | Revue médicale suisse | | 2015 | 405 | 1 | ||
| Prise en charge des facteurs de risque des maladies cardiovasculaires : qu'est-ce qui a vraiment changé en 15 ans ? | Revue médicale suisse | | 2015 | 427 | 1 | ||
| Edulcorants artificiels et diabète : faux amis ? | Revue médicale suisse | | 2015 | 399 | 0 | ||
| ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content | Journal of Lipid Research | | 2015 | 470 | 0 | ||
| Serum Vitamin D Concentrations Are Not Associated with Insulin Resistance in Swiss Adults | The Journal of nutrition | | 2015 | 541 | 0 | ||
| Transition en diabétologie | Revue médicale suisse | | 2015 | 560 | 1 | ||
| Diets and nonalcoholic fatty liver disease: The good and the bad | Clinical nutrition | | 2014 | 675 | 1 | ||
| Capsule Commentary on Patrick et al., Trends in Insulin Initiation and Treatment Intensification among Patients with Type 2 Diabetes | Journal of general internal medicine | | 2014 | 596 | 1 | ||
| Maladies hépatiques chroniques et diabète | Revue médicale suisse | | 2014 | 490 | 0 | ||
| Traitement combiné d'insuline et d'analogue du GLP-1 : qu'en attendre ? | Revue médicale suisse | | 2014 | 574 | 0 | ||
| Ostα-/- mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity | American Journal of Physiology. Gastrointestinal and Liver Physiology | | 2014 | 457 | 0 | ||
| Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice | Diabetologia | | 2014 | 503 | 0 | ||
| Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice | Endocrinology | | 2013 | 764 | 0 | ||
| CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance | Proceedings of the National Academy of Sciences | | 2013 | 503 | 0 | ||
| Increased FGF21 plasma levels in humans with sepsis and SIRS | Endocrine connections | | 2013 | 636 | 283 | ||
| Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside | Diabetes & metabolism | | 2013 | 640 | 0 | ||
| Enhanced fasting glucose turnover in mice with disrupted action of TUG protein in skeletal muscle | Journal of Biological Chemistry | | 2013 | 507 | 0 | ||
| Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance | Endocrinology | | 2013 | 465 | 0 | ||
| Sport et diabète de type 1 | Revue médicale suisse | 2013 | 674 | 0 | |||
| Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance | Journal of Endocrinology | | 2013 | 677 | 0 | ||
| Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance | Endocrinology | | 2012 | 462 | 0 | ||
| Development of insulin resistance in mice lacking PGC-1α in adipose tissues | Proceedings of the National Academy of Sciences | | 2012 | 418 | 0 | ||
| Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice | Journal of Biological Chemistry | | 2012 | 438 | 0 | ||
| Sommeil et diabète | Revue médicale suisse | | 2012 | 511 | 0 | ||
| Diabète et stéatose hépatique non alcoolique | Revue médicale suisse | | 2012 | 631 | 0 | ||
| Weight and mortality in adults with diabetes | JAMA | | 2012 | 595 | 0 | ||
| Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients | Acta Diabetologica | | 2012 | 439 | 0 | ||
| Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice | Cell Metabolism | | 2011 | 456 | 0 | ||
| Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance | Hepatology | | 2011 | 446 | 1 | ||
| Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome | Journal of Clinical Endocrinology and Metabolism | | 2011 | 480 | 0 | ||
| SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function | Diabetes | | 2011 | 398 | 0 | ||
| Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2 | Proceedings of the National Academy of Sciences | | 2011 | 504 | 0 | ||
| Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance | Cell Metabolism | | 2010 | 468 | 0 | ||
| A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain | American Journal of Physiology. Endocrinology and Metabolism | | 2010 | 444 | 0 | ||
| Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals | Diabetologia | | 2010 | 643 | 0 | ||
| Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients | NMCD. Nutrition Metabolism and Cardiovascular Diseases | | 2009 | 644 | 0 | ||
| Mucocutaneous papillomatous papules in Cowden's syndrome | Clinical and experimental dermatology | | 2008 | 556 | 0 | ||
| Assessment of hepatic glucose metabolism by indirect calorimetry in combination with a non-invasive technique using naturally enriched 13C glucose in healthy children and adolescents | Hormone Research | | 2004 | 428 | 0 | ||
| Metabolism of oral glucose in children born small for gestational age: evidence for an impaired whole body glucose oxidation | Metabolism | | 2004 | 434 | 0 | ||
| Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 | The Journal of clinical endocrinology and metabolism | | 2003 | 638 | 0 |
